Third COVID-19 Vaccine Authorized

FDA issues Emergency Use Authorization for the Janssen COVID-19 vaccine

Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S for use in individuals 18 years of age and older.

U.S. Food and Drug Administration, February 27, 2021

For more information, read the news release from the FDA.